162 related articles for article (PubMed ID: 19127567)
1. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.
Hunger SP; Sung L; Howard SC
Pediatr Blood Cancer; 2009 May; 52(5):559-65. PubMed ID: 19127567
[TBL] [Abstract][Full Text] [Related]
2. Childhood cancer epidemiology in low-income countries.
Howard SC; Metzger ML; Wilimas JA; Quintana Y; Pui CH; Robison LL; Ribeiro RC
Cancer; 2008 Feb; 112(3):461-72. PubMed ID: 18072274
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I.
Howard SC; Marinoni M; Castillo L; Bonilla M; Tognoni G; Luna-Fineman S; Antillon F; Valsecchi MG; Pui CH; Ribeiro RC; Sala A; Barr RD; Masera G;
Pediatr Blood Cancer; 2007 Mar; 48(3):364-9. PubMed ID: 16883601
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.
Hinds PS; Hockenberry MJ; Gattuso JS; Srivastava DK; Tong X; Jones H; West N; McCarthy KS; Sadeh A; Ash M; Fernandez C; Pui CH
Cancer; 2007 Nov; 110(10):2321-30. PubMed ID: 17926333
[TBL] [Abstract][Full Text] [Related]
5. [Individualized cancer treatment. Illustrated by acute lymphoblastic leukemia in children].
Schmiegelow K
Ugeskr Laeger; 2001 Feb; 163(8):1062-6. PubMed ID: 11242663
[TBL] [Abstract][Full Text] [Related]
6. Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years.
Kulkarni KP; Arora RS; Marwaha RK
J Pediatr Hematol Oncol; 2011 Aug; 33(6):475-9. PubMed ID: 21792045
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results.
Abboud MR; Ghanem K; Muwakkit S
Curr Opin Oncol; 2014 Nov; 26(6):650-5. PubMed ID: 25202926
[TBL] [Abstract][Full Text] [Related]
8. New decision support tool for treatment intensity choice in childhood acute lymphoblastic leukemia.
Pedreira CE; Macrini L; Land MG; Costa ES
IEEE Trans Inf Technol Biomed; 2009 May; 13(3):284-90. PubMed ID: 19423428
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of childhood acute lymphoblastic leukemia.
Brenner TL; Pui CH; Evan WE
Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood acute lymphoblastic leukemia.
Stanulla M; Schrappe M
Semin Hematol; 2009 Jan; 46(1):52-63. PubMed ID: 19100368
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic strategies in acute lymphoblastic leukemia.
Jeha S
Semin Hematol; 2009 Jan; 46(1):76-88. PubMed ID: 19100370
[TBL] [Abstract][Full Text] [Related]
12. Pediatric regimens for adult acute lymphoblastic leukemia.
Stock W
Clin Adv Hematol Oncol; 2009 Apr; 7(4):244-6. PubMed ID: 19521325
[No Abstract] [Full Text] [Related]
13. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
Cole PD; Kamen BA
Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
[TBL] [Abstract][Full Text] [Related]
14. Early postinduction intensification therapy is essential in childhood acute lymphoblastic leukemia.
Henze G
Nat Clin Pract Oncol; 2008 Sep; 5(9):502-3. PubMed ID: 18648353
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.
Sutton R; Venn NC; Tolisano J; Bahar AY; Giles JE; Ashton LJ; Teague L; Rigutto G; Waters K; Marshall GM; Haber M; Norris MD;
Br J Haematol; 2009 Aug; 146(3):292-9. PubMed ID: 19500099
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
Pui CH; Jeha S
Nat Rev Drug Discov; 2007 Feb; 6(2):149-65. PubMed ID: 17268486
[TBL] [Abstract][Full Text] [Related]
17. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia.
Ozdemir MA; Karakukcu M; Patiroglu T; Torun YA; Kose M
Acta Haematol; 2009; 121(1):56-62. PubMed ID: 19339772
[TBL] [Abstract][Full Text] [Related]
18. Strategies to improve outcomes of children with cancer in low-income countries.
Howard SC; Ribeiro RC; Pui CH
Eur J Cancer; 2005 Jul; 41(11):1584-7. PubMed ID: 15979305
[No Abstract] [Full Text] [Related]
19. Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
Douer D
Best Pract Res Clin Haematol; 2008 Dec; 21(4):647-58. PubMed ID: 19041604
[TBL] [Abstract][Full Text] [Related]
20. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
Kaspers GJ; Zwaan CM
Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
